Esophageal neoplasia
Conditions
Interventions
Endoscopic screening using AFI was performed.
Endoscopic screening using AFI was performed by experienced and less-experienced endoscopists.
Sponsors
Osaka Medical Center for Cancer and Cardiovascular Diseases
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) patients with present esophageal neoplasias, (2) patients with past history of esophageal neoplasias treated with endoscopic resection, (3) patients with present or past history of head and neck cancer.
Exclusion criteria
Exclusion criteria: Patients were excluded if they had previously undergone an operation, chemotherapy or radiotherapy for esophageal cancer, or had undergone chromoendoscopy with iodine staining within 6 months or allergic to iodine solution.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome variable in this study was the sensitivity of AFI on a per lesion basis. | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) The positive predictive value (PPV) of NBI in a per lesion basis; (2) the sensitivity, specificity, PPV, negative predictive value (NPV) and accuracy of AFI in a per patient basis. (3) The differences in sensitivities, specificities, NPVs, PPVs and accuracy with regard to study periods, endoscopists, lesions' size and HGIN or invasive cancer. | — |
Countries
Japan
Contacts
Public ContactRyu Ishihara
Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Gastrointestinal Oncology
Outcome results
None listed